Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 270 followers
Latest posts
Last updated about 1 hour ago
Human medicines European public assessment report (EPAR): Xromi, hydroxycarbamide, Date of authorisation: 01/07/2019, Revision: 9, Status: Authorised
about 1 hour ago
Human medicines European public assessment report (EPAR): Xromi, hydroxycarbamide, Date of authorisation...
Human medicines European public assessment report (EPAR): BroPair Spiromax, salmeterol,fluticasone propionate, Date of authorisation: 26/03/2021, Revision: 3, Status: Authorised
about 19 hours ago
Human medicines European public assessment report (EPAR): BroPair Spiromax, salmeterol,fluticasone propionate, Date...
Human medicines European public assessment report (EPAR): Spevigo, spesolimab, Date of authorisation: 09/12/2022, Revision: 2, Status: Authorised
about 20 hours ago
Human medicines European public assessment report (EPAR): Spevigo, spesolimab, Date of authorisation...
Human medicines European public assessment report (EPAR): Foclivia, pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted), Date of authorisation: 18/10/2009, Revision: 14, Status: Authorised
about 20 hours ago
Human medicines European public assessment report (EPAR): Foclivia, pandemic influenza vaccine (H5N1)...
Human medicines European public assessment report (EPAR): Xbryk, denosumab, Date of authorisation: 12/02/2025, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Xbryk, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Yargesa, miglustat, Date of authorisation: 22/03/2017, Revision: 6, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Yargesa, miglustat, Date of authorisation...
Human medicines European public assessment report (EPAR): Benlysta, belimumab, Date of authorisation: 13/07/2011, Revision: 37, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Benlysta, belimumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Imvanex, smallpox and monkeypox vaccine (Live Modified Vaccinia Virus Ankara), Date of authorisation: 31/07/2013, Revision: 30, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Imvanex, smallpox and monkeypox vaccine...
Human medicines European public assessment report (EPAR): Rivastigmine Actavis, rivastigmine, Date of authorisation: 16/06/2011, Revision: 21, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Rivastigmine Actavis, rivastigmine, Date of...
Human medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation: 13/01/2025, Revision: 1, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation...
Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation: 08/09/2003, Revision: 94, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Viread, tenofovir disoproxil, Date of authorisation: 04/02/2002, Revision: 60, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Viread, tenofovir disoproxil, Date of...